Skip directly to content

How we do business

As one of the world’s premier innovative research-based biopharmaceutical companies, we are dedicated to applying our science, skills, people and resources to saving lives, preventing illness and improving health.

We are committed to developing medicines, vaccines and consumer healthcare products to help improve and save the lives of people in the UK and across the world.

We provide medicines for many common illnesses and conditions - such as cardiovascular disease, pain and arthritis - right through to medicines for rarer conditions, such as certain types of cancer or rare diseases that afflict only small numbers of people.

We invest time, knowledge and money in discovering, developing and delivering innovative new medicines and vaccines for the benefit of patients. We are prioritising our efforts in areas with the greatest scientific and commercial promise – tackling some of the most feared diseases of our time, such as cancer and Alzheimer’s.

We work with the NHS, health care providers, patient organisations, Government, NGOs and many other organisations to improve the health of people in the UK.

Alongside our commercial and financial responsibilities, we recognise our wider responsibilities to society. We work in partnership with our stakeholders and customers to play an active role in local communities across the UK and across the globe.

To ensure we can continue to deliver on our commitments to the patients, customers and shareholders who rely on us, we are focused on improving the way we do business; on operating with transparency in everything we do; and on listening to the views of all of the people involved in healthcare decisions.

To help us to do this, our business operates inside our Code of Conduct, as well as the regulations that govern the pharmaceutical industry globally and in the UK.